Javascript must be enabled for this website to work.

#script { display:none; } #noScript{ width: 350px; height: 175px; text-align: center; background: white; padding: 35px; display: block; margin-top: -87px; top: 50%; position: absolute; border-bottom: 1px solid #c2c2c2; border-left: 1px solid #e6e6e6; border-right: 1px solid #e6e6e6; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; margin-left: 50%; left: -175px; } #noScript img{width:100%;} body{background:#f7f7f7;}

Updated COPD-X guide reflects stronger evidence for triple therapy

LRTI rates fall by 30% in Indigenous infants but still a long way to go

Make telehealth items a permanent feature for specialists: AMA

No need to ‘reinvent the wheel’ on post-COVID rehab programs, say clinicians

CPAP helps with sleep but not dysfunctional breathing

COPD

NIV improves outcomes in hospitalised COPD patients

By Mardi Chapman

19 Jul 2017

A Cochrane Review has confirmed that non-invasive bi-level positive pressure ventilation (NIV) should form part of the initial management of patients admitted to hospital with acute hypercapnic respiratory failure due to acute COPD exacerbations. The systematic review, including 17 trials comprising 1264 participants, found the addition of NIV to usual care reduced the risk of ...

Already a member?

Forgot my password

Not a member yet?

Join now for free, independent news relevant to your specialty. the limbic is intended for practicing health care professionals only.

Title: *

First name: *

Last name: *

Country: *

Email: *

Password: *

Password must contain at least 8 characters including 1 letter and 1 number.

AHPRA Number: * Find my AHPRA number

What's your primary area of interest? *

The limbic's weekly newsletter is a round up of key news highlights that's relevant to your specialty. The newsletter may contain advertising and educational or promotional material from carefully selected industry partners including pharmaceutical companies, government and not-for-profit organisations.

You will not receive advertisers only emails and your details will not be shared with any other party.

I would like to receive the limbic newsletter *

I have read and agree to the limbic Terms and Conditions & Privacy Policy *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Top Stories